207 related articles for article (PubMed ID: 26795290)
1. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
2. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
Seki C; Ito H; Ichimiya T; Arakawa R; Ikoma Y; Shidahara M; Maeda J; Takano A; Takahashi H; Kimura Y; Suzuki K; Kanno I; Suhara T
Ann Nucl Med; 2010 May; 24(4):249-60. PubMed ID: 20364374
[TBL] [Abstract][Full Text] [Related]
4. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.
Lopresti BJ; Klunk WE; Mathis CA; Hoge JA; Ziolko SK; Lu X; Meltzer CC; Schimmel K; Tsopelas ND; DeKosky ST; Price JC
J Nucl Med; 2005 Dec; 46(12):1959-72. PubMed ID: 16330558
[TBL] [Abstract][Full Text] [Related]
5. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
Price JC; Klunk WE; Lopresti BJ; Lu X; Hoge JA; Ziolko SK; Holt DP; Meltzer CC; DeKosky ST; Mathis CA
J Cereb Blood Flow Metab; 2005 Nov; 25(11):1528-47. PubMed ID: 15944649
[TBL] [Abstract][Full Text] [Related]
6. Generation of synthetic PET images of synaptic density and amyloid from
Wang R; Liu H; Toyonaga T; Shi L; Wu J; Onofrey JA; Tsai YJ; Naganawa M; Ma T; Liu Y; Chen MK; Mecca AP; O'Dell RS; van Dyck CH; Carson RE; Liu C
Med Phys; 2021 Sep; 48(9):5115-5129. PubMed ID: 34224153
[TBL] [Abstract][Full Text] [Related]
7. Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements.
McNamee RL; Yee SH; Price JC; Klunk WE; Rosario B; Weissfeld L; Ziolko S; Berginc M; Lopresti B; Dekosky S; Mathis CA
J Nucl Med; 2009 Mar; 50(3):348-55. PubMed ID: 19223409
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of reference regions for (R)-[(11)C]PK11195 studies in Alzheimer's disease and mild cognitive impairment.
Kropholler MA; Boellaard R; van Berckel BN; Schuitemaker A; Kloet RW; Lubberink MJ; Jonker C; Scheltens P; Lammertsma AA
J Cereb Blood Flow Metab; 2007 Dec; 27(12):1965-74. PubMed ID: 17406654
[TBL] [Abstract][Full Text] [Related]
9. Quantification of dopamine transporter binding using [18F]FP-beta-CIT and positron emission tomography.
Yaqub M; Boellaard R; van Berckel BN; Ponsen MM; Lubberink M; Windhorst AD; Berendse HW; Lammertsma AA
J Cereb Blood Flow Metab; 2007 Jul; 27(7):1397-406. PubMed ID: 17191076
[TBL] [Abstract][Full Text] [Related]
10. Simplified parametric methods for [18F]FDDNP studies.
Yaqub M; Tolboom N; van Berckel BN; Scheltens P; Lammertsma AA; Boellaard R
Neuroimage; 2010 Jan; 49(1):433-41. PubMed ID: 19643186
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of methods for generating parametric (R-[11C]PK11195 binding images.
Schuitemaker A; van Berckel BN; Kropholler MA; Kloet RW; Jonker C; Scheltens P; Lammertsma AA; Boellaard R
J Cereb Blood Flow Metab; 2007 Sep; 27(9):1603-15. PubMed ID: 17311080
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18).
Wong DF; Rosenberg PB; Zhou Y; Kumar A; Raymont V; Ravert HT; Dannals RF; Nandi A; Brasić JR; Ye W; Hilton J; Lyketsos C; Kung HF; Joshi AD; Skovronsky DM; Pontecorvo MJ
J Nucl Med; 2010 Jun; 51(6):913-20. PubMed ID: 20501908
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.
Catafau AM; Danus M; Bullich S; Llop J; Perich J; Cunningham VJ; Plaza P; Penengo MM; Eersels JL; Squassante L; Ros D; Barbanoj M
J Nucl Med; 2006 Jun; 47(6):919-28. PubMed ID: 16741300
[TBL] [Abstract][Full Text] [Related]
14. Test-retest repeatability of [
Timmers T; Ossenkoppele R; Visser D; Tuncel H; Wolters EE; Verfaillie SC; van der Flier WM; Boellaard R; Golla SS; van Berckel BN
J Cereb Blood Flow Metab; 2020 Dec; 40(12):2464-2474. PubMed ID: 31575335
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans.
Frokjaer VG; Pinborg LH; Madsen J; de Nijs R; Svarer C; Wagner A; Knudsen GM
J Nucl Med; 2008 Feb; 49(2):247-54. PubMed ID: 18199621
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
[TBL] [Abstract][Full Text] [Related]
17. Optimal scanning time window for 18F-FP-(+)-DTBZ (18F-AV-133) summed uptake measurements.
Lin KJ; Lin WY; Hsieh CJ; Weng YH; Wey SP; Lu CS; Skovronsky D; Yen TC; Chang CJ; Kung MP; Hsiao IT
Nucl Med Biol; 2011 Nov; 38(8):1149-55. PubMed ID: 21831650
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and 28-day test-retest repeatability and reproducibility of [
Tuncel H; Boellaard R; Coomans EM; de Vries EF; Glaudemans AW; Feltes PK; García DV; Verfaillie SC; Wolters EE; Sweeney SP; Ryan JM; Ivarsson M; Lynch BA; Schober P; Scheltens P; Schuit RC; Windhorst AD; De Deyn PP; van Berckel BN; Golla SS
J Cereb Blood Flow Metab; 2021 Jun; 41(6):1338-1350. PubMed ID: 34013797
[TBL] [Abstract][Full Text] [Related]
19. [(18)F]Fallypride dopamine D2 receptor studies using delayed microPET scans and a modified Logan plot.
Tantawy MN; Jones CK; Baldwin RM; Ansari MS; Conn PJ; Kessler RM; Peterson TE
Nucl Med Biol; 2009 Nov; 36(8):931-40. PubMed ID: 19875049
[TBL] [Abstract][Full Text] [Related]
20. The spatial extent of tauopathy on [
Gérard T; Colmant L; Malotaux V; Salman Y; Huyghe L; Quenon L; Dricot L; Ivanoiu A; Lhommel R; Hanseeuw B
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1662-1674. PubMed ID: 38228971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
